313 related articles for article (PubMed ID: 12913097)
1. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma.
Vos MJ; Hoekstra OS; Barkhof F; Berkhof J; Heimans JJ; van Groeningen CJ; Vandertop WP; Slotman BJ; Postma TJ
J Clin Oncol; 2003 Oct; 21(19):3559-65. PubMed ID: 12913097
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 SPECT as response parameter for PCV chemotherapy in recurrent glioma.
Roesdi MF; Postma TJ; Hoekstra OS; van Groeningen CJ; Wolbers JG; Heimans JJ
J Neurooncol; 1998 Dec; 40(3):251-5. PubMed ID: 10066098
[TBL] [Abstract][Full Text] [Related]
3. Thallium-201 SPECT: the optimal prediction of response in glioma therapy.
Vos MJ; Berkhof J; Postma TJ; Hoekstra OS; Barkhof F; Heimans JJ
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):222-7. PubMed ID: 16193315
[TBL] [Abstract][Full Text] [Related]
4. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors.
Matsunaga S; Shuto T; Takase H; Ohtake M; Tomura N; Tanaka T; Sonoda M
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):47-52. PubMed ID: 22541963
[TBL] [Abstract][Full Text] [Related]
5. Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography.
Carvalho PA; Schwartz RB; Alexander E; Garada BM; Zimmerman RE; Loeffler JS; Holman BL
J Neurosurg; 1992 Oct; 77(4):565-70. PubMed ID: 1527616
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
Gómez-Río M; Rodríguez-Fernández A; Ramos-Font C; López-Ramírez E; Llamas-Elvira JM
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):966-75. PubMed ID: 18172642
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
[TBL] [Abstract][Full Text] [Related]
8. Use of 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas.
Vallejos V; Balaña C; Fraile M; Roussos Y; Capellades J; Cuadras P; Ballester R; Ley A; Arellano A; Rosell R
J Neurooncol; 2002 Aug; 59(1):81-90. PubMed ID: 12222842
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden.
Lorberboym M; Baram J; Feibel M; Hercbergs A; Lieberman L
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):249-54. PubMed ID: 7721624
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of 201Tl SPECT and CT in the follow-up of irradiated brain tumors.
Datta NR; Pasricha R; Gambhir S; Prasad SN; Phadke RV
Int J Clin Oncol; 2004 Feb; 9(1):51-8. PubMed ID: 15162827
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.
Tie J; Gunawardana DH; Rosenthal MA
J Clin Neurosci; 2008 Dec; 15(12):1327-34. PubMed ID: 18845440
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
13. Postoperative residual tumour imaged by contrast-enhanced computed tomography and 201Tl single photon emission tomography: can they predict progression-free survival in high-grade gliomas?
Datta NR; Pasricha R; Gambhir S; Phadke RV; Prasad SN
Clin Oncol (R Coll Radiol); 2004 Oct; 16(7):494-500. PubMed ID: 15490813
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of the diagnostic accuracy of 201Tl single photon emission computed tomography in the detection of recurrent glioma.
Vos MJ; Tony BN; Hoekstra OS; Postma TJ; Heimans JJ; Hooft L
Nucl Med Commun; 2007 Jun; 28(6):431-9. PubMed ID: 17460533
[TBL] [Abstract][Full Text] [Related]
16. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography.
Kosuda S; Fujii H; Aoki S; Suzuki K; Tanaka Y; Nakamura O; Shitara N
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1201-6. PubMed ID: 7961030
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of 201Tl-SPECT and MRI using Gd-DTPA for glioma].
Yamada T; Maruoka S; Yamada S; Sonobe M
Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jul; 59(8):402-8. PubMed ID: 10459285
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of malignancy and viability of brain tumors by 201Tl SPECT: the correlation between 201Tl SPECT and pathology, clinical progress and the intensity of enhancement on CT images].
Ohnishi H; Koizumi K; Uchiyama G; Yamaguchi M; Okada J; Ogata H; Toyama K; Monzawa S; Oba H; Araki T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1388-98. PubMed ID: 7596768
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
Stokkel M; Stevens H; Taphoorn M; Van Rijk P
Nucl Med Commun; 1999 May; 20(5):411-7. PubMed ID: 10404525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
